Analgesic and Anti‐inflammatory Potential of Merged Pharmacophore Containing 1,2,4‐triazoles and Substituted Benzyl Groups via Thio Linkage

A plethora of non‐steroidal anti‐inflammatory drugs are available in the market with adverse side effects like gastrointestinal irritation, bleeding, and ulceration. Currently, the focus of researcher on the development of better, synergistic molecules by the hybridization of two or more active biomolecule or ligands to develop newer derivative possessing good anti‐inflammatory activity with minimum side effects. In line with this, the present study was designed to synthesize a series of merged pharmacophore contaning1,2,4‐triazoles and substituted benzyl groups via thio linkage. Purity of the derivatives was confirmed by thin‐layer chromatography, combustion analysis, and melting point. Structure of these derivatives was set up by determining infrared spectroscopy, nuclear magnetic resonance spectroscopy, and mass spectroscopy. All the synthesized derivatives were evaluated for their analgesic and anti‐inflammatory activities in mice and rats, respectively. In animal studies, the derivative 3‐(5‐(4‐nitrobenzylthio)‐4H‐1,2,4‐triazol‐3‐yl) pyridine showed more potent analgesic activity, and the derivative 3‐(5‐(2,4‐dimethylbenzylthio)‐4H‐1,2,4‐triazol‐3‐yl) pyridine showed more potent anti‐inflammatory activity as compared with other derivatives. The results of the present study indicate that reaction of pyridine linked 1,2,4‐triazole‐3‐thiol with different substituted benzyl halides to produce merged pharmacophore contaning1,2,4‐triazoles and substituted benzyl groups with potent analgesic and anti‐inflammatory activities. Docking studies were performed by using Argus lab, and all the derivatives exhibited good docking scores between −10 and −12 kcal/mol and were better as compared with standard drugs aspirin and indomethacin against cyclooxygenase‐2. Among all compounds, 3j has shown the maximum docking score and found in agreement to in pharmacological activities.     

One‐Pot Multicomponent Synthesis of Novel 2‐Tosyloxyphenylpyrans under Green and Conventional Condition with Anti‐inflammatory Activity

A mild, efficient, and environmentally green protocol for the synthesis of 2‐tosyloxyphenylpyran derivatives 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 via reaction of 2‐tosyloxybenzaldehyde ( 1 ) with malononitrile and some ketonic reagents in one‐pot, three component reaction within few minutes under stirring in methanol in presence of ammonium hydroxide solution or ultrasonic irradiation. On the other hand, the same products 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 were obtained by traditional method, on treatment of 2‐tosyloxybenzilidinemalononitrile ( 2 ) with the same ketonic reagents in refluxing ethanol in presence of TEA. 2‐Tosyloxyphenylpyranopyrazoles 12 and 13 were obtained via treatment of compound 1 with malononitrile, hydrazine hydrate or phenyl hydrazine and ethyl acetoacetate, in one‐pot, multicomponent reaction (MCRs). The structures of the new compounds were elucidated by elemental and spectral analyses. The newly synthesized compounds showed promising anti‐inflammatory activity.     

Synthesis of Bis‐acridine Derivatives Exhibiting Anticancer and Anti‐inflammatory Activity

A series of bis‐acridine derivatives 3a – j and 5a – j have been synthesized by condensation of 9‐chloro‐2,4‐(un)substituted acridines (1a – e) and 9‐isothiocyanato‐2,4‐(un)substituted acridines (4a – e) with diamine 2a and 2b , respectively. These bis‐acridines were evaluated in vitro for activity against a panel of human cancer cell lines of lung (NCI H‐522), ovary (PA1), breast (T47D), colon (HCT‐15), and liver (HepG2). Several bis‐acridines were found to possess good anticancer activity against various cancer cell lines. Of these, compound 3h exhibited good anticancer activity against all cancer cell lines tested except liver (HepG2) cell line. In addition to this, these compounds were screened for anti‐inflammatory activity at a dose of 50 mg/kg p.o. Compound 3g exhibited 41% anti‐inflammatory activity, which is better than most commonly used standard drug ibuprofen, which showed 39% anti‐inflammatory (at 50 mg/kg p. o.) activity.     

Synthesis of Some New Azoloazines with Potent Anti‐inflammatory and Analgesic Activity

Starting from pyrimidine‐2‐thiones, a set of new fused triazoles, thiazoles, and thiazines has been obtained. The mechanistic pathway and structures of all the novel products were ascertained on the foundation of spectral information and elemental analyses. The analgesic and anti‐inflammatory activities of all the prepared compounds were predestined. The outcomes disclosed that all of the examined samples revealed potent activity. Moreover, the relation between the structure and the activity has been researched.     

Synthesis and Characterization of Some Heteroaromatic Derivatives of 3‐But‐2‐enoyl‐chromen‐2‐one and Their Potential as Anti‐inflammatory Agents

A novel series of chromen‐2‐ones containing pyrazole, isoxazole, oxazine, and thiazine substitutions have been synthesized by reacting 3‐[3‐(4‐chloro‐phenyl)‐acryloyl]‐chromen‐2‐one and 3‐[3‐(3‐methoxy‐phenyl)‐acryloyl]‐chromen‐2‐one with various cyclizing agents such as hydrazine, phenylhydrazine, urea, and thiourea. The structures of all the synthesized compounds were confirmed by the use of IR, ¹H‐NMR, mass spectroscopy, and elemental analysis data. All the newly synthesized compounds were evaluated for their anti‐inflammatory activity at a dose of 100 mg/kg body weight in carrageenan‐induced rat paw edema model. The entire series of the compounds exhibited moderate to good anti‐inflammatory activity, with the percentage inhibition of edema formation ranging from 39.99 to 63.15 against the reference drug ibuprofen (100 mg/kg) that showed 78.96% inhibition at the third hour. Compounds 3a , 3c , and 3d showed good inhibitory activity, whereas compounds 3b , 3e , 3f , and 3j showed moderate inhibitory activity at the third hour.     

Regioselective Synthesis of Pyrazoles and Isoxazoles with Cyclopropanated Side‐Chain

Pyrazoles and isoxazoles with cyclopropanated side‐chain were prepared by cyclization of cyclopropanated 1,3,5‐tricarbonyl compounds with hydrazine and hydroxylamine, respectively. The regioselectivity is influenced by the reaction conditions.     

Microwave‐assisted Synthesis of Novel 3,4‐Bis‐chalcone‐N‐arylpyrazoles and Their Anti‐inflammatory Activity

A series of 3,4‐bis‐chalcone‐N‐arylpyrazoles 3a‐h was prepared conveniently from diacetyl pyrazoles 2a,b . All reactions were carried out under conventional thermal heating and/or microwave irradiation. The structure of the latter functionally pyrazoles was confirmed under the bases of their IR, mass, ¹H NMR and ¹³C NMR. The X‐ray diffraction of compound 3e not only confirmed the chemical structure of 3a‐h , but also showed the E configuration of their chalcone moieties. Treatment of compound 3e with phenyl hydrazine in presence of acetic acid afforded the tri‐pyrazle 4 . The anti‐inflammatory activity of the newly synthesized compounds was investigated. Some of these compounds showed a moderate activity when compared with indomethacin as a reference drug. The combination between chalcone and pyrazole moieties revealed a variable effect in anti‐inflammatory activity.     

Enhanced In Vitro Antitumor Efficacy and Strong Anti‐Cell‐Migration Activity of a Hydroxycamptothecin‐Encapsulated Magnetic Nanovehicle

A 10‐hydroxycamptothecin‐encapsulated magnetic nanovehicle (HEMN) was fabricated by coencapsulating Fe₃O₄ nanoparticles and 10‐hydroxycamptothecin (HCPT) into a micelle core self‐assembled from the amphiphilic copolymer methoxy‐poly(ethylene glycol)–poly(d,l ‐lactide‐co‐glycolide) through a facile dialysis method. A satisfactory drug‐loading content of (9.03±0.67) % and a relatively high encapsulation efficiency of (53.52±6.46) % were achieved. In vitro drug release was performed by membrane dialysis and a pH‐dependent release behavior was observed. In comparison with free HCPT dissolved in dimethylsulfoxide, HEMNs showed a greatly improved in vitro antitumor efficacy against three different human cancer cell lines—HeLa, A549, and HepG2—and lower IC₅₀ values were measured. The mechanism of cell death was investigated, and it was clearly demonstrated that the apoptosis process was triggered. An in vitro wound‐healing assay and a transwell assay indicated that HEMNs exerted much stronger activity in inhibiting HeLa cell migration. The cellular uptake of HEMNs in a desired area can be significantly enhanced by an external magnetic field. These results demonstrate HCPT‐encapsulated magnetic nanovehicles might have important potential in clinical applications for inhibiting tumor metastasis and for targeted drug delivery.     

Three‐Phase Photocatalysis for the Enhanced Selectivity and Activity of CO2 Reduction on a Hydrophobic Surface

The photocatalytic CO₂ reduction reaction (CRR) represents a promising route for the clean utilization of stranded renewable resources, but poor selectivity resulting from the competing hydrogen evolution reaction (HER) in aqueous solution limits its practical applicability. In the present contribution a photocatalyst with hydrophobic surfaces was fabricated. It facilitates an efficient three‐phase contact of CO₂ (gas), H₂O (liquid), and catalyst (solid). Thus, concentrated CO₂ molecules in the gas phase contact the catalyst surface directly, and can overcome the mass‐transfer limitations of CO₂, inhibit the HER because of lowering proton contacts, and overall enhance the CRR. Even when loaded with platinum nanoparticles, one of the most efficient HER promotion cocatalysts, the three‐phase photocatalyst maintains a selectivity of 87.9 %. Overall, three‐phase photocatalysis provides a general and reliable method to enhance the competitiveness of the CRR.     

Synthesis of New Pyrazoles via Cycloaddition Reactions of Nitrilimines with 2‐Cyclopentenone Derivatives

Compounds 1,3,6,6a‐tetraphenyl‐1,6a‐dihydrocyclopenta[c]pyrazol‐4(3aH)‐ones ( 3 ), 1,3,3a,4‐tetraphenyl‐1,3a‐dihydrocyclopenta[c]pyrazol‐6‐ols ( 4 ) and 6‐hydroxy‐1,3,6,6a‐tetraphenyl‐1,5,6,6a‐tetrahydrocyclopenta[c]pyrazole‐4(aH)‐one ( 5 ) were synthesized by reaction of 3,4‐diphenyl‐4‐hydroxy‐2‐cyclopentenone ( 2a ) with nitrilimines, generated in situ by the action of triethylamine on the corresponding hydrazonyl chlorides 1 .     

Design,Synthesis and Biological Evaluation of Potent Azadipeptide Nitrile Inhibitors and Activity‐Based Probes as Promising Anti‐Trypanosoma brucei Agents

Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas disease and African sleeping sickness, respectively. There is an urgent need for the development of new drugs against both diseases due to the lack of adequate cures and emerging drug resistance. One promising strategy for the discovery of small‐molecule therapeutics against parasitic diseases has been to target the major cysteine proteases such as cruzain for T. cruzi, and rhodesain/TbCatB for T. brucei. Azadipeptide nitriles belong to a novel class of extremely potent cysteine protease inhibitors against papain‐like proteases. We herein report the design, synthesis, and evaluation of a series of azanitrile‐containing compounds, most of which were shown to potently inhibit both recombinant cruzain and rhodesain at low nanomolar/picomolar ranges. A strong correlation between the potency of rhodesain inhibition (i.e., target‐based screening) and trypanocidal activity (i.e., whole‐organism‐based screening) of the compounds was observed. To facilitate detailed studies of this important class of inhibitors, selected hit compounds from our screenings were chemically converted into activity‐based probes (ABPs), which were subsequently used for in situ proteome profiling and cellular localization studies to further elucidate potential cellular targets (on and off) in both the disease‐relevant bloodstream form (BSF) and the insect‐residing procyclic form (PCF) of Trypanosoma brucei. Overall, the inhibitors presented herein show great promise as a new class of anti‐trypanosome agents, which possess better activities than existing drugs. The activity‐based probes generated from this study could also serve as valuable tools for parasite‐based proteome profiling studies, as well as bioimaging agents for studies of cellular uptake and distribution of these drug candidates. Our studies therefore provide a good starting point for further development of these azanitrile‐containing compounds as potential anti‐parasitic agents.     

Determination of Nonsteroidal Anti‐inflammatory Drugs in Serum by Microchip Capillary Electrophoresis with Electrochemical Detection

A simple and rapid method has been developed for the analysis of four nonsteroidal anti‐inflammatory drugs (NSAIDs) in serum using microchip capillary electrophoresis with pulsed amperometric detection. The selected NSAIDs (salicylic acid, acetaminophen, diflunisal, and diclofenac) are among the most commonly used drugs to treat fever, inflammation, and pain. Used above the therapeutic levels, these drugs can cause a wide variety of adverse effects and their fast analysis could have a significant impact in treatment and recovery of the patients. Several conditions, including separation potential, pH, and concentration of the electrolyte solution were studied to optimize the separation and detection. In this study, salicylic acid, acetaminophen, diflunisal, and diclofenac were separated in less than 2 minutes using a 5 mM borate buffer at pH 11.5 and a separation potential of +1200 V. Linear relationships were obtained between the concentration and peak current in the 0.5–15.3 μg/mL range and detection limits around 0.26 μg/mL. After 30 consecutive injections, the stability of both the response and migration time of the analytes showed relative related deviations of less than 4.6% and 1.0%, respectively. The potential of this method was verified by spiking a bovine serum sample with the four NSAIDs and analyzing the recovery ratio.     

Synthesis and Biological Evaluation of 2‐substituted‐6‐(morpholinyl/piperidinyl)pyridazin‐3(2H)‐ones as Potent and Safer Anti‐inflammatory and Analgesic Agents

A series of 2‐substituted‐6‐(morpholinyl/piperidinyl)pyridazin‐3(2H )‐ones was synthesized and the structures were established using various spectroscopic techniques. The target compounds were screened for anti‐inflammatory and analgesic activities at 20 and 40 mg/kg. The safety of the synthesized derivatives was evaluated by assessing anti‐platelet activity and ulcer index. The obtained pharmacological data revealed that 6‐morpholinyl derivatives 4a–12a were found to be somewhat more potent than 6‐piperidinyl derivatives 4b–6b. The 6‐morpholinyl substituted pyridazinone 12a exhibited maximum anti‐inflammatory and analgesic activities. Homoveratrylamine substituted compounds 6a and 6b emerged as promising leads in both the series with good anti‐inflammatory and analgesic activities without any ulcerogenicity. Anti‐platelet activity results of the compounds of both the series showed significantly low bleeding time in comparison with standard drug aspirin indicating the cardiovascular safety of new pyridazinones.     

Nonsteroidal Anti‐inflammatory Drug‐based N‐Allylidene Benzohydrazides and 1‐Acyl‐2‐pyrazolines: Their Synthesis as Potential Cytotoxic Agents In Vitro

A series of 1‐acyl‐2‐pyrazoline derivatives derived from nonsteroidal anti‐inflammatory drugs was designed as potential anticancer agents. Synthesis of these compounds was carried out via the condensation reaction of chalcones and acid hydrazides under heating. The methodology did not require the use of any costly reagents or catalysts, and the acid hydrazide reactants were readily prepared from mefenamic acid or ibuprofen. A variety of 1‐acyl‐2‐pyrazolines was prepared in good to excellent yields. An N‐allylidene benzohydrazide intermediate was isolated during the reaction optimization study, the structure of which was confirmed unambiguously by X‐ray single crystal data. A range of N‐allylidene benzohydrazides were also prepared in good yields. Some of the compounds synthesized showed promising cytotoxic activities when tested against HCT‐15 human colon cancer cell line in vitro.     

Syntheses and Functional Studies of Self‐Adjuvanting Anti‐HER2 Cancer Vaccines

The 9‐mer peptide MFCH401 (N: 165–173: DTILWKDIF), which is located in the extracellular domain of HER2, has been predicted to be a novel epitope. Self‐adjuvanting anti‐HER2 vaccine constructs were designed and synthesized via covalently attaching MFCH401 or its linear tandem repeats (2×MFCH401, 3×MFCH401) to a lipopeptide Pam₃CSK₄ via iterative condensation reaction. The in vivo results showed the Pam₃CSK₄‐MFCH401 vaccine construct can induce higher antibody titers of IgG and IgM than those of other conjugates, and the analysis of changes in plasma cytokines level indicate the activation of Th1 cells and NK cells. In addition, the Pam₃CSK₄‐MFCH401 vaccine conjugate induced a specific immune response to HER2‐overexpressing human BT474 cells. Our data clearly indicated that MFCH401 is a promising epitope; moreover, its linear tandem repeats were unsuitable for anticancer vaccine design when conjugating with Pam₃CSK₄, which provided useful evidence for developing further anti‐HER2 cancer vaccines.     

Synthesis of Some Novel Heterocycles Bearing Thiadiazoles as Potent Anti‐inflammatory and Analgesic Agents

2‐Bromoacetyl‐3‐phenyl‐1,3,4‐thiadiazole derivative was synthesized and reacted with a number of heterocyclic amines to give a series of fused imidazole derivatives. Also, reaction of 2‐bromoacetyl‐3‐phenyl‐1,3,4‐thiadiazole with o‐phenylene diamine and 2‐aminothiophenol yielded the respective products. Moreover, reaction of 2‐bromoacetyl‐3‐phenyl‐1,3,4‐thiadiazole with thiourea, thiosemicarbazide, thiocarbahydrazide gave the respective thiazoles. The structures of all the novel products were elucidated on the basis of elemental analysis and spectral data. In addition, the biological activity of the newly synthesized compounds was evaluated, and the results obtained indicate their potency as anti‐inflammatory, analgesic, and anti‐ulcer agents. The binding mechanism of the most active compounds was studied using MOE to analyze the molecular interactions.     

Synthesis and Anti‐inflammatory Screening of Some Mono and Bis‐Alkoxyphthalimide Linked Benzimidazole and their Quinazoline and Pyrimidine Derivatives

In the present study, synthesis of some nonsymmetrical 2‐(1H‐benzimidazol‐2‐ylamino)‐7,7‐dimethyl‐7,8‐dihydroquinazolin‐5(6H)‐one ( 3 ) and substituted‐(1H‐benzo[d]imidazol‐2‐yl)amino‐pyrimidine derivatives ( 4a , 4b , 4c and 5a , 5b ) is described as a three‐component reaction of 2‐guanidinobenzimidazole ( 2 ) with triethyl orthoformate and different reactive methylene compounds. Subsequent condensation of compounds 3 , 4a , 4b , 4c , and 5a , 5b with bromoethoxyphthalimide ( 1 ) gave final compounds 6 , 7a , 7b , 7c , and 8a , 8b . Synthesized final compounds have been screened for their in‐vivo anti‐inflammatory activity against carrageenan‐induced paw edema in albino rats. Diclofenac was used as standard anti‐inflammatory agents. Some of the compounds exhibited significant anti‐inflammatory activity, as compared to standard drug. Structures of synthesized compounds have been confirmed on the basis of chemical tests and spectral studies.     

Enhanced Performance of Organic Photovoltaic Cells Fabricated with a Methyl Thiophene‐3‐Carboxylate‐Containing Alternating Conjugated Copolymer

A new donor‐acceptor copolymer, containing benzodithiophene (BDT) and methyl thiophene‐3‐carboxylate (3MT) units, is designed and synthesized for polymer solar cells (PSCs). The 3MT unit is used as an electron acceptor unit in this copolymer to provide a lower highest occupied molecular orbital (HOMO) level for obtaining polymer solar cells with a higher open‐circuit voltage (V_OC). The resulting bulk heterojunction PSC made of the copolymer and [6,6]‐phenyl‐C71‐butyric acid methyl ester (PC₇₁BM) exhibits a power conversion efficiency (PCE) up to 4.52%, a short circuit current (J_SC) of 10.5 mA·cm‐², and a V_OC of 0.86 V.     

Hydrophobic Modification of Pd/SiO2@Single‐Site Mesoporous Silicas by Triethoxyfluorosilane: Enhanced Catalytic Activity and Selectivity for One‐Pot Oxidation

To enhance the catalytic activity in a selective one‐pot oxidation using in‐situ generated H₂O₂, a hydrophobically modified core–shell catalyst was synthesized by means of a simple silylation reaction using the fluorine‐containing silylation agent triethoxyfluorosilane (TEFS, SiF(OEt)₃). The catalyst consisted of a Pd‐supported silica nanosphere and a mesoporous silica shell containing isolated Ti^IV and F ions bonded with silicon (Si?F bond). Structural analyses using XRD and N₂ adsorption–desorption suggested that the mesoporous structure and large surface area of the mesoporous shells were retained even after the modification. During the one‐pot oxidation of sulfide, catalytic activity was enhanced significantly by increasing the amount of fluorine in the shell. A hydrophobic surface enhanced adsorption of the hydrophobic reactant into the mesopore, while the less hydrophobic oxygenated products efficiently diffused into the outside of the shell, which improved the catalytic activity and selectivity. In addition, the present methodology can be used to enhance the catalytic activity and selectivity in the one‐pot oxidation of cyclohexane by using an Fe‐based core–shell catalytic system.